The story has been updated to include comments from Exact Sciences' conference call.

NEW YORK (GenomeWeb News) – Exact Sciences today reported flat revenues year over year for the first quarter.

The Madison, Wis.-based company reported revenues of $1.0 million for the three months ended March 31, even with the year-ago period and matching the average Wall Street estimate.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.